Dr Lal Path Labs Part 3 | Stock Review & Rating | Governance & Summary

Dr Lal Path Labs Part 3 | Stock Review & Rating | Governance & Summary

Published on 25 Oct 2019
.Views 3 .Comments 1

Methodology Video

Share On

3 Part Analysis & rating of Dr Lal PathLabs - leading diagnotic chains in India market leadership in North India and wide presence across India. First diagnostic company to get listed on Indian stock exchange and one of the authorised chains for COVID-19 testing

You like to know more. We like that!

Please subscribe Stock-O-Meter Plus Plan to get access of all premium stock articles Only at Rs 9,999.00/Year.

Recently Uploaded

View All

Chat on WhatsApp